| Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center: Structure, Innovations, and Initial Outcomes RR Reams, FT Odedina, JD Carpten, K Redda, MC Stern, JL Krieger, ... Cancer Control 30, 10732748231197878, 2023 | 1 | 2023 |
| Experience with nataluzimab use, JCV antibody testing and treatment decisions E Williamson, L Buchbinder, K Plascencia, M Bravo, J Aparicio, M Burnett MULTIPLE SCLEROSIS JOURNAL 18, 229-229, 2012 | 1 | 2012 |
| EBV Prevalence and Overall Survival in the Multi ethnic Study of Hodgkin Lymphoma (MESH) E Lam, JY Wan, J Aparicio, S Pullarkat, A Colombo, JY Song, C Chao, ... Blood 142, 6188, 2023 | | 2023 |
| Evaluation of a Prognostic 23-Gene Expression Panel in a Set of 390 Multiethnic Hodgkin Lymphoma Patients A Colombo, JY Wan, A Jiang, J Aparicio, E Lam, T Aoki, JY Song, ... Blood 142, 4379, 2023 | | 2023 |
| HIV-Associated Hodgkin Lymphoma Has Increased CD8 T-Cells and NK Cells in the Tumor Microenvironment VR Sethapati, P Tizro, M Nwangwu, W Cozen, J Aparicio, I Siddiqi, ... LABORATORY INVESTIGATION 102 (SUPPL 1), 1018-1019, 2022 | | 2022 |
| Characteristics of and Risk Factors for Monoclonal Gammopathy of Undetermined Significance (MGUS) in the Multiethnic Cohort Study M Salehi, DO Stram, JA Aparicio, L Aguinada, VK Cortessis, MJ Marin, ... BLOOD 136, 2020 | | 2020 |
| Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors by race/ethnicity in a multiethnic US population R Bolanos, A Hwang, J Aparicio, C Chao, N Qurashi, C Flowers, ... CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 29 (6), 2020 | | 2020 |
| Abstract B092: Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors by race/ethnicity in a multiethnic US population R Bolanos, A Hwang, J Aparicio, C Chao, N Qurashi, C Flowers, ... Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_2), B092-B092, 2020 | | 2020 |
| Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors is explained by histologic subtype, not race/ethnicity in a multiethnic US population R Bolanos, A Hwang, C Chao, C Flowers, S Pullarkat, J Aparicio, S Wang, ... Cancer Research 79 (13_Supplement), 5053-5053, 2019 | | 2019 |
| Epstein-Barr Virus prevalence in classic Hodgkin lymphoma is predicted by histologic subtype and not race or ethnicity a multiethnic US cohort R Bolanos, A Hwang, C Chao, C Flowers, S Pullarkat, J Aparicio, S Wang, ... LABORATORY INVESTIGATION 99, 2019 | | 2019 |
| A non-randomized, open label, exploratory study of dalfampridine-extended release and sexual dysfunction in women with multiple sclerosis R Berkovich, J Aparicio, L Tarlow, A Palomeque, L Amezcua MULTIPLE SCLEROSIS JOURNAL 22, 383-384, 2016 | | 2016 |
| Modulation of mononuclear cell homeostasis following gilenya treatment: preferential expansion of multiple regulatory cell populations EE Kelland, G Agadjanyan, AM Levy, F Gutierrez, J Aparicio, ... MULTIPLE SCLEROSIS JOURNAL 22, 783-784, 2016 | | 2016 |
| Are Recent Hispanic Immigrants At Higher Risk Of Disability With Multiple Sclerosis?(S34. 008) L Amezcua, K Ladezma, M Eslami, J Aparicio, A Langer-Gould Neurology 82 (10 Supplement), 2014 | | 2014 |
| The Diagnosis of Multiple Sclerosis in Hispanics Occurs Sooner in the Young than in Adults (P5. 159) M Langille, L Amezcua, M Burnett, J Aparicio, W Mitchell Neurology 82 (10 Supplement), 2014 | | 2014 |
| Update on Experience with Natalizumab Use, JCV Antibody Testing & Treatment Decisions at the University of Southern California MS Center–Including Sex Differences (P01. 213) E Williamson, J Aparicio, L Buckbinder, M Burnett Neurology 80 (7 Supplement), P01. 213-P01. 213, 2013 | | 2013 |
| Expanded Laboratory Surveillance for PML in a Large Cohort of Patients on Natalizumab for Multiple Sclerosis L Amezcua, R Berkovich, M Burnett, J Aparicio, N Kachuck NEUROLOGY 74 (9), A419-A419, 2010 | | 2010 |
